OMERS Administration Corp’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.94M Buy
158,311
+1,110
+0.7% +$77.3K 0.06% 139
2025
Q4
$10.4M Buy
157,201
+128,005
+438% +$8.28M 0.07% 120
2025
Q3
$1.96M Hold
29,196
0.01% 418
2025
Q2
$2.55M Hold
29,196
0.02% 295
2025
Q1
$1.99M Buy
29,196
+3,066
+12% +$250K 0.02% 391
2024
Q4
$2.03M Sell
26,130
-3,425
-12% -$254K 0.02% 328
2024
Q3
$1.98M Hold
29,555
0.02% 399
2024
Q2
$3.35M Buy
+29,555
New +$3.74M 0.03% 221
2016
Q4
Sell
-36,000
Closed -$789K 390
2016
Q3
$789K Hold
36,000
0.01% 393
2016
Q2
$714K Hold
36,000
0.01% 386
2016
Q1
$611K Hold
36,000
0.01% 379
2015
Q4
$737K Buy
+36,000
New +$749K 0.02% 318

Other funds holding DXCM

OMERS Administration Corp's DXCM Position: Q1 2026 in Review

OMERS Administration Corp increased its DexCom (DXCM) stake by 0.71% in Q1 2026, buying an estimated $77.3K and bringing the position to 158,311 shares worth $9.94M. The position accounts for 0.06% of the portfolio, ranked #139.

OMERS Administration Corp first reported a position in DXCM in Q4 2015 and has held it in 12 quarters since. The position peaked at $10.4M in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • OMERS Administration Corp held 158,311 shares of DexCom worth $9.94M as of Q1 2026.
  • OMERS Administration Corp bought 1,110 DexCom shares in Q1 2026, an estimated $77.3K.
  • DexCom made up 0.06% of OMERS Administration Corp's portfolio in Q1 2026, its #139 holding.
  • OMERS Administration Corp first reported a position in DexCom in Q4 2015 and has held it in 12 quarters since.
  • OMERS Administration Corp's DexCom position peaked at $10.4M in Q4 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.